CHO Pharma (ROCO:6586) Receivables Turnover : 4.27 (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is CHO Pharma Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. CHO Pharma's Revenue for the six months ended in Dec. 2024 was NT$2.50 Mil. CHO Pharma's average Accounts Receivable for the six months ended in Dec. 2024 was NT$0.59 Mil. Hence, CHO Pharma's Receivables Turnover for the six months ended in Dec. 2024 was 4.27.

CHO Pharma Receivables Turnover Historical Data

The historical data trend for CHO Pharma's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CHO Pharma Receivables Turnover Chart

CHO Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Receivables Turnover

Get a 7-Day Free Trial

56.67

0.95

4.77

CHO Pharma Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Receivables Turnover	Get a 7-Day Free Trial															-	-	-	2.58	4.27

Competitive Comparison of CHO Pharma's Receivables Turnover

For the Biotechnology subindustry, CHO Pharma's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CHO Pharma's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CHO Pharma's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where CHO Pharma's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

CHO Pharma Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

CHO Pharma's Receivables Turnover for the fiscal year that ended in Dec. 2024 is calculated as

	Receivables Turnover (A: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2024 )	/ (	(Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )
=	3.58	/ (	(0	+	0.751)	/	1 )
=	3.58	/	0.751
=	4.77

CHO Pharma's Receivables Turnover for the quarter that ended in Dec. 2024 is calculated as

	Receivables Turnover (Q: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2024 )	/ (	(Accounts Receivable (Q: Jun. 2024 )	+	Accounts Receivable (Q: Dec. 2024 ))	/	count )
=	2.498	/ (	(0.42	+	0.751)	/	2 )
=	2.498	/	0.5855
=	4.27

CHO Pharma (ROCO:6586) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

CHO Pharma Receivables Turnover Related Terms

Thank you for viewing the detailed overview of CHO Pharma's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

CHO Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CHO Pharma Inc (ROCO:6586) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Park Street, 18F, Building F, Nangang, Taipei, TWN, 11503

Website

http://www.chopharma.com

CHO Pharma Inc is a biopharmaceutical company mainly focused on the development and commercialization of innovative products based on the proprietary glycan engineering technologies. It offers antibodies, such as CHO-H01, CHO-H02, CHO-A04 for cancer; CHO-H03, an antibody for autoimmune disease; CHO-S05 dual-effect anti-flu drugs; and CHO-V06 glycan-based vaccines and drugs.

CHO Pharma Headlines

No Headlines